Related Experiment Video

Updated: Jun 27, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Nek2 as a novel molecular target for the treatment of breast carcinoma

Nobuyuki Tsunoda1, Toshio Kokuryo, Koji Oda

  • 1Division of Surgical Oncology, Nagoya University, Graduate School of Medicine, 65-Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.

Cancer Science
|November 29, 2008
PubMed

Insights

Nek2 kinase is highly expressed in breast cancer cells and drives tumor growth, invasion, and colony formation. Targeting Nek2 with siRNA effectively reduced tumor size in preclinical models, suggesting its potential as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Nek2 is a serine-threonine kinase implicated in cell cycle regulation.
  • Aberrant Nek2 expression is observed in various cancers, but its specific role in breast carcinoma tumorigenesis requires further elucidation.

Purpose of the Study:

  • To investigate the role of Nek2 in the tumorigenic growth of breast carcinoma.
  • To evaluate Nek2 as a potential therapeutic target for both estrogen receptor-positive and ER-negative breast cancers.

Main Methods:

  • Immunoblotting was used to assess Nek2 expression in multiple breast carcinoma cell lines.
  • Nek2 short interfering RNA (siRNA) was employed to reduce Nek2 expression in vitro and in vivo.
  • Cell proliferation, soft agar colony formation, and in vitro invasion assays were performed.
  • A xenograft nude mouse model was utilized to assess the effect of Nek2 siRNA on tumor growth.

Main Results:

  • Nek2 expression was elevated across all examined breast carcinoma cell lines.
  • Nek2 siRNA treatment significantly suppressed cell growth, colony formation, and invasiveness in vitro.
  • In vivo, Nek2 siRNA administration led to a reduction in tumor size in a xenograft mouse model.
  • These effects were observed in both estrogen receptor-positive (MCF7) and ER-negative (MDA-MB-231) breast cancer models.

Conclusions:

  • Nek2 plays a critical role in promoting the tumorigenic growth of breast carcinoma cells.
  • Nek2 inhibition, via siRNA, demonstrates significant anti-tumor effects in preclinical models.
  • Nek2 represents a promising therapeutic molecular target for breast carcinoma treatment, irrespective of ER status.

More Related Videos

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...